This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Fed's QE3 Is the Drug the Market Craves

Stocks in this article: ^DJI

BOSTON ( TheStreet) -- The Federal Reserve has turned into the ultimate pusher, and quantitative easing is the drug that investors want badly. The question now is whether any good would come of allowing the central bank to continue to enable the markets.

Witness Tuesday's dramatic sell-off following the latest statement on interest rates, which was followed by a dramatic surge into the closing bell and an equally dramatic plunge at the open Wednesday. The Dow Jones Industrial Average, which rocketed higher by more than 250 points in the last half hour of trading Tuesday, gave back that gain and more.

Federal Reserve Chairman Ben Bernanke

"You have effectively taken those gains away and we are where we traded yesterday before the Fed announcement," says Paul Nolte, director of investment with Dearborn Partners in Chicago. "Should we have rallied 400 points on the Dow? No. We're right back to focusing on debt issues and the unrest in England. Those things below the surface are indicative of a larger problem that we aren't solving."

However, investors still believe in the implicit guarantee, or the so-called "Bernanke put," that the Fed will purchase Treasuries in order to keep prices afloat. In its statement, the central bank said it will leave interest rates low until mid-2013 as economic growth has been "considerably slower" than the Fed expected.

"The Committee will regularly review the size and composition of its securities holdings and is prepared to adjust those holdings as appropriate," the statement from the Federal Open Market Committee reads. "The Committee discussed the range of policy tools available to promote a stronger economic recovery in a context of price stability."

Those promises seemed to be the wink and nod that investors had been hoping for. It wasn't an explicit promise, but it was enough to boost equity markets on Tuesday.

"The markets are addicted to that heroin, so to speak," says Lance Roberts, chief strategist at Streettalk Advisors. "The markets know they have that 'Bernanke put' in place. You didn't have a direct statement in terms of 'we're going to start QE3.' Saying that the economy is weaker than they anticipated is a set-up statement for QE3."

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,614.81 +215.14 1.31%
S&P 500 1,941.28 +37.27 1.96%
NASDAQ 4,419.4780 +103.4040 2.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs